FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Expedited IND to Lean on Rolling Submissions/Reviews

FDA officials detailing the agencys new expedited IND pilot program say a central feature will be a rolling pre-IND submission process.

latest-news-card-1
Human Drugs

Lilly Files Six Lawsuits Over Illegal Retatrutide Sales

Eli Lilly files six new lawsuits against U.S. entities it alleges are selling illegal, unapproved retatrutide products.

latest-news-card-1
Human Drugs

Ban Infants Tylenol: Childrens Health Defense

Childrens Health Defense petitions FDA to ban Infants Tylenol and place Boxed Warnings on labeling for some other Tylenol products.

latest-news-card-1
Human Drugs

Use More Advisory Committee Temporary Voting Members: Column

A Center for Medicine in the Public Interest opinion column calls on FDA to more aggressively recruit and use advisory committee temporary voting memb...

latest-news-card-1
Human Drugs

FDA Obstacles Lead to Overseas Trials: Survey

A survey of 37 biotech executives shows FDA obstacles are sending more first-in-human trials overseas.

latest-news-card-1
Human Drugs

Theresa Mullin Retires as CDER Associate Director

CDER associate Center director for strategic initiatives Theresa Mullin retires after 28 years at the agency.

latest-news-card-1
Human Drugs

FDA Guide Updates Procedures for Formal Drug/Biologic Meetings

FDA posts an updated guidance outlining procedures for formal meetings between the agency and sponsors or applicants developing or seeking approval fo...

latest-news-card-1
Medical Devices

Hamilton Medical Removes Breathing Circuit Set

An updated Class 1 recall notice says Hamilton Medical is recommending that certain coaxial breathing circuit sets used with HAMILTON-C1, HAMILTON T-1...

latest-news-card-1
Human Drugs

Belite Bio Files NDA for Stargardt Disease

FDA accepts for priority review a Belite Bio NDA for tinlarebant for treating Stargardt Disease Type 1.

latest-news-card-1
Human Drugs

New Pathway Sought for Albuterol Inhalation Aerosol Products

A petition submitted to FDA calls for the agency to create conditional nonprescription access to albuterol sulfate inhalers.